MedpacevsMerck & Company

MEDP and MRK stock compared: price, dividend, valuation and results, from SEC filings.

MEDP

Medpace Holdings, Inc.

$644.56

Value $18.3B

-0.36%
MEDP's page

MRK

Merck & Company, Inc.

$134.13

Value $332B

-2.45%
MRK's page

Medpace (MEDP) has a market value of $18.3B and Merck & Company (MRK) $332B. Over the last year, with dividends, MEDP moved +9.2% and MRK +43.2%. The P/E is 35.3 for MEDP and 135.2 for MRK. Dividend yield: MEDP none, MRK 2.53%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MEDP$18.3B

    MRK$332B

    MRK is 18 times MEDP

  • Revenue, 12 months

    MEDP$2.8B

    MRK$67.4B

    MRK is 24 times MEDP

  • Net income, 12 months

    MEDP$518M

    MRK$2.5B

    MRK is 4.7 times MEDP

  • Operating margin

    MEDP21.4%

    MRK–

  • ROIC

    MEDP105.8%

    MRK3.9%

    101.9 points apart

  • P/E

    MEDP35.3

    MRK135.2

    MRK is 3.8 times MEDP

  • Dividend yield

    MEDP0.0%

    MRK2.5%

    2.5 points apart

  • 5-year return

    MEDP+184.9%

    MRK+88.1%

    96.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MEDP+184.9%

MRK+88.1%

10020030020222023202420252026
Returns by period
PeriodMEDPWith dividendsMRKWith dividends
1 year since November 18, 2025+9.2%Price +9.2%+43.2%Price +39.1%
3 years since November 17, 2023+135.2%+33.0% a yearPrice +135.2%+44.4%+13.0% a yearPrice +31.8%
5 years since November 18, 2021+184.9%+23.3% a yearPrice +184.9%+88.1%+13.5% a yearPrice +61.5%
10 years since November 21, 2016+1,693.4%+33.5% a yearPrice +1,693.4%+206.1%+11.8% a yearPrice +125.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MEDPMedpaceMRKMerck & Company

Valuation

MEDPMRK
Valuation
Price$644.56$134.13
Market value$18.3B$332B
Enterprise value (EV)$17.6B$376B
P/E35.3135.2
P/E, 5-year median34.514.8
P/B31.37.4
EV/EBIT29.078.9
Free cash flow yield3.7%4.5%

Results and growth

MEDPMRK
Results and growth
Revenue, 12 months$2.8B$67.4B
Net income, 12 months$518M$2.5B
Free cash flow, 12 months$668M$14.7B
Earnings per share, 12 months$18.01$0.98
Revenue growth, year on year20.0%1.3%
Revenue growth a year, past+22.3%over 5 years+9.4%over 5 years
EPS growth a year, past+31.8%over 5 years+21.2%over 5 years

Margins and returns on capital

MEDPMRK
Margins and returns on capital
Gross margin–71.8%
Operating margin21.4%–
Net margin18.2%3.6%
ROIC105.8%3.9%
ROE109.3%5.2%

Balance sheet

MEDPMRK
Balance sheet
Cash$705M$9.7B
Total debt$171M$53.8B
Net debt / EBITDA-1.15.7
Interest cover–2.4×

Dividends and buybacks

MEDPMRK
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield5.0%1.5%
Shareholder yield5.0%4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MEDP or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Medpace or Merck & Company?

By market value, Merck & Company ($332B) is about 18.1 times Medpace ($18.3B), at today's prices.

How did MEDP and MRK stock do over the last 10 years?

Since November 21, 2016, MEDP's price moved +1,693.4% and MRK's +125.6%. With dividends: MEDP +1,693.4% (+33.5% a year), MRK +206.1% (+11.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, MEDP or MRK?

The dividend yield at today's price is none for Medpace and 2.53% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of MEDP and MRK?

At today's price, the P/E is 35.3 for MEDP and 135.2 for MRK. The median of the last five years was 34.5 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Medpace or Merck & Company?

Over the last twelve months, the net margin was 18.2% for Medpace and 3.6% for Merck & Company, and the operating margin 21.4% and –. Revenue was $2.8B and $67.4B.

Which is the better investment, Medpace or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.